F-4614

N/A

Report date: 2024/12/12 16:37:24

Base Information

Drug NameF-4614
Drug Alias NameRGD-V29
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIshihara Sangyo Kaisha
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIshihara Sangyo Kaisha
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A